318 related articles for article (PubMed ID: 25022196)
1. Tyrosine phosphorylation in Toll-like receptor signaling.
Chattopadhyay S; Sen GC
Cytokine Growth Factor Rev; 2014 Oct; 25(5):533-41. PubMed ID: 25022196
[TBL] [Abstract][Full Text] [Related]
2. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors.
Nishiya T; DeFranco AL
J Biol Chem; 2004 Apr; 279(18):19008-17. PubMed ID: 14976215
[TBL] [Abstract][Full Text] [Related]
3. Constitutively Bound EGFR-Mediated Tyrosine Phosphorylation of TLR9 Is Required for Its Ability To Signal.
Veleeparambil M; Poddar D; Abdulkhalek S; Kessler PM; Yamashita M; Chattopadhyay S; Sen GC
J Immunol; 2018 Apr; 200(8):2809-2818. PubMed ID: 29531172
[TBL] [Abstract][Full Text] [Related]
4. The inducible nitric-oxide synthase (iNOS)/Src axis mediates Toll-like receptor 3 tyrosine 759 phosphorylation and enhances its signal transduction, leading to interferon-β synthesis in macrophages.
Hsieh MY; Chang MY; Chen YJ; Li YK; Chuang TH; Yu GY; Cheung CH; Chen HC; Maa MC; Leu TH
J Biol Chem; 2014 Mar; 289(13):9208-20. PubMed ID: 24526685
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor-mediated tyrosine phosphorylation of paxillin via MyD88-dependent and -independent pathways.
Hazeki K; Masuda N; Funami K; Sukenobu N; Matsumoto M; Akira S; Takeda K; Seya T; Hazeki O
Eur J Immunol; 2003 Mar; 33(3):740-7. PubMed ID: 12616494
[TBL] [Abstract][Full Text] [Related]
6. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
Arsenault RJ; Kogut MH; He H
Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptors 2 and 4 activate STAT1 serine phosphorylation by distinct mechanisms in macrophages.
Rhee SH; Jones BW; Toshchakov V; Vogel SN; Fenton MJ
J Biol Chem; 2003 Jun; 278(25):22506-12. PubMed ID: 12686553
[TBL] [Abstract][Full Text] [Related]
8. SCIMP is a universal Toll-like receptor adaptor in macrophages.
Luo L; Curson JEB; Liu L; Wall AA; Tuladhar N; Lucas RM; Sweet MJ; Stow JL
J Leukoc Biol; 2020 Feb; 107(2):251-262. PubMed ID: 31468585
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad.
François S; El Benna J; Dang PM; Pedruzzi E; Gougerot-Pocidalo MA; Elbim C
J Immunol; 2005 Mar; 174(6):3633-42. PubMed ID: 15749901
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand.
Nagase H; Okugawa S; Ota Y; Yamaguchi M; Tomizawa H; Matsushima K; Ohta K; Yamamoto K; Hirai K
J Immunol; 2003 Oct; 171(8):3977-82. PubMed ID: 14530316
[TBL] [Abstract][Full Text] [Related]
11. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance.
Medvedev AE; Piao W; Shoenfelt J; Rhee SH; Chen H; Basu S; Wahl LM; Fenton MJ; Vogel SN
J Biol Chem; 2007 Jun; 282(22):16042-53. PubMed ID: 17392283
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation.
Fonte E; Agathangelidis A; Reverberi D; Ntoufa S; Scarfò L; Ranghetti P; Cutrona G; Tedeschi A; Xochelli A; Caligaris-Cappio F; Ponzoni M; Belessi C; Davis Z; Piris MA; Oscier D; Ghia P; Stamatopoulos K; Muzio M
Haematologica; 2015 Nov; 100(11):1460-8. PubMed ID: 26294727
[TBL] [Abstract][Full Text] [Related]
13. Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?
O'Neill LA
Nat Clin Pract Rheumatol; 2008 Jun; 4(6):319-27. PubMed ID: 18446139
[TBL] [Abstract][Full Text] [Related]
14. Development of SH2 probes and pull-down assays to detect pathogen-induced, site-specific tyrosine phosphorylation of the TLR adaptor SCIMP.
Luo L; Tong SJ; Wall AA; Khromykh T; Sweet MJ; Stow JL
Immunol Cell Biol; 2017 Jul; 95(6):564-570. PubMed ID: 28290451
[TBL] [Abstract][Full Text] [Related]
15. Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity.
Kurt-Jones EA; Sandor F; Ortiz Y; Bowen GN; Counter SL; Wang TC; Finberg RW
J Endotoxin Res; 2004; 10(6):419-24. PubMed ID: 15588425
[TBL] [Abstract][Full Text] [Related]
16. MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction.
Gray P; Dunne A; Brikos C; Jefferies CA; Doyle SL; O'Neill LA
J Biol Chem; 2006 Apr; 281(15):10489-95. PubMed ID: 16439361
[TBL] [Abstract][Full Text] [Related]
17. Tumor progression locus 2-dependent oxidative burst drives phosphorylation of extracellular signal-regulated kinase during TLR3 and 9 signaling.
Kuriakose T; Rada B; Watford WT
J Biol Chem; 2014 Dec; 289(52):36089-100. PubMed ID: 25378393
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory actions of Syk inhibitors in macrophages involve non-specific inhibition of toll-like receptors-mediated JNK signaling pathway.
Lin YC; Huang DY; Chu CL; Lin WW
Mol Immunol; 2010 Apr; 47(7-8):1569-78. PubMed ID: 20138367
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases.
Poghosyan Z; Robbins SM; Houslay MD; Webster A; Murphy G; Edwards DR
J Biol Chem; 2002 Feb; 277(7):4999-5007. PubMed ID: 11741929
[TBL] [Abstract][Full Text] [Related]
20. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
